000 | 02014 a2200553 4500 | ||
---|---|---|---|
005 | 20250516060711.0 | ||
264 | 0 | _c20120907 | |
008 | 201209s 0 0 eng d | ||
022 | _a1569-8041 | ||
024 | 7 |
_a10.1093/annonc/mdr438 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEjlertsen, B | |
245 | 0 | 0 |
_aPrognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cMay 2012 |
||
300 |
_a1138-1144 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
650 | 0 | 4 |
_aCarcinoma _xdiagnosis |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aDenmark |
650 | 0 | 4 |
_aEstrogen Receptor alpha _xanalysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aPostmenopause _xgenetics |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aAldridge, J | |
700 | 1 | _aNielsen, K V | |
700 | 1 | _aRegan, M M | |
700 | 1 | _aHenriksen, K L | |
700 | 1 | _aLykkesfeldt, A E | |
700 | 1 | _aMüller, S | |
700 | 1 | _aGelber, R D | |
700 | 1 | _aPrice, K N | |
700 | 1 | _aRasmussen, B B | |
700 | 1 | _aViale, G | |
700 | 1 | _aMouridsen, H | |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 23 _gno. 5 _gp. 1138-1144 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdr438 _zAvailable from publisher's website |
999 |
_c21219787 _d21219787 |